Pathology Doctors in Columbus, IN Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Dr. Pamela Browning Robertson, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5141    Fax: 812-376-5431

Mark E Fons, DO Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-418-0014

David Michael O'brien, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 3961 S Summit Ln, Columbus, IN 47201 Phone: 812-342-4149

Dr. Bret R Huber, DO Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-336-6821    Fax: 419-866-5453

Dr. Maryann L Bridge, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5144    Fax: 812-376-5431

News Archive

Ritual for orthodox Jewish men may offer cardiovascular health benefits, study suggests

A pilot study led by researchers at the University of Cincinnati College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily prayer, may receive cardiovascular health benefits.

New report highlights need for improved safety measures in organ procurement travel

The transplant community was largely unaware of sub-standard transportation practices for donor organs until a number of fatal air crashes took the lives of transplant personnel, calling attention to procurement aviation safety.

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

A recent study published in the preprint server medRxiv in July 2020 shows that this is indeed possible. The development of this inexpensive but reliable and sensitive test could change the face of preventive measures for COVID-19 in low-resource settings.

Targeting mutant BRAF can kill cancer cells, but cannot finish off melanoma

This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.

Read more Medical News

› Verified 4 days ago